SCHEMBL28043893

SCHEMBL28043893

CNc1cc(-c2cccc(OC)c2)nc(N)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.55
TSHR P16473 2/20 0.55
TP53 P04637 1/20 0.55
MAPT P10636 1/20 0.55
ALOX15 P16050 1/20 0.55
MAPK1 P28482 1/20 0.55
HTT P42858 1/20 0.55
KMT2A Q03164 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
HSD17B10 Q99714 1/20 0.55
ADORA1 P30542 4/20 0.52
ADORA2A P29274 4/20 0.52
ADORA2B P29275 3/20 0.52
ADORA3 P0DMS8 2/20 0.52
NUDT1 P36639 3/20 0.51
SCN2A Q99250 2/20 0.50
AURKA O14965 1/20 0.50
PDPK1 O15530 1/20 0.50
TGFBR1 P36897 1/20 0.50
ROCK1 Q13464 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15757669 0.84 DYRK1A (0.67) HPGDTSHRTP53MAPTALOX15
SCHEMBL31295947 0.82 DYRK1A (0.69) HPGDTSHRADORA1ADORA2AADORA2B
SCHEMBL15756951 0.82 NUDT1 (0.56) HPGDTSHRMAPTKMT2AADORA1
SCHEMBL15757289 0.81 NUDT1 (0.58) ADORA1ADORA2ANUDT1AURKAPDPK1
SCHEMBL5751719 0.81 HSP90AA1 (0.54) HPGDTSHRADORA1ADORA2AADORA2B
SCHEMBL17407824 0.80 HRH4 (0.68) HPGDTSHRTP53MAPTALOX15
SCHEMBL28822368 0.79 NUDT1 (0.54) MAPTKMT2AADORA1ADORA2AADORA2B
SCHEMBL1644371 0.79 HSP90AA1 (0.61) HPGDTSHRADORA1ADORA2AADORA2B
SCHEMBL31295981 0.79 PTGDR (0.69) HPGDTSHRTP53MAPTALOX15
SCHEMBL14748394 0.79 TP53 (0.52) HPGDTSHRTP53MAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-A Pyrimidine-2,4-diamine derivatives for treatment of cancer THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING 2015-12-09 CN disclosed